MRI T2* Mapping of Myocardium, Liver, Pancreas and Pituitary Gland
NCT ID: NCT04835285
Last Updated: 2021-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
152 participants
INTERVENTIONAL
2020-01-21
2023-01-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Miocardium, pancreas and pituitary gland T2\* relaxometry maps were calculated automatically by commertial application ReportCARD Functool (GE Healthcare) and integrated Philips T2\* maps. Then for selected ROI T2\* data acquisition in milisecond \[ms\] were performed and calculated automatically.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study of Non-Invasive Assessment of Hepatic And Myocardial Iron Through T2* Magnet Resonance Imaging (MRI) In Patients With Iron Overload
NCT00675038
Evaluation of Myocardial Iron Deposition in Patients of Heart Failure Using T2* MR Imaging
NCT02527330
Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration
NCT00587535
Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis
NCT02099214
Massive Iron Deposit Assessment
NCT01572922
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The placement of region of interest (ROI) in target organ were performed by following criterion: for the myocardium - in the interventricular septum in short axis plane; for the pancreas - in corpus in axial plane; for the pituitary gland - in adenohypophysis; for all organs the area of large and small blood vessels, which can introduce distortions of the obtained results were excluded. Then for selected ROI T2\* data acquisition in milisecond \[ms\] were performed and calculated automatically by approximating the attenuation curve with the highest likelihood method.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Npf.
3T MRI and 1,5 T MRI scanners. For myocardium, pancreas and pituitary gland iron overload
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. A history of transfusion-dependent anemia of various origins.
3. indications for the appointment of chelation therapy
1. Age over 25 y.o.
2. The number of RBC transfusions previously received by the patient is less than 10
Exclusion Criteria
2. Refusal to sign the informed consent.
6 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Galina f Tereshchenko, PhD
Role: STUDY_DIRECTOR
Chief radiology department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology
Moscow, Samory-Mashela,1, Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCPHOI-2019-09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.